Thursday January 5th, 2017

Launch of the VisioCyt1 clinical trial

Thursday January 5th, 2017|

VitaDX launches today its first clinical trial VisioCyt 1. This multicentric study on 1300 patients aims to evaluate the diagnostic performances of the VisioCyt® test.

Tuesday December 20th, 2016

Wednesday November 23rd, 2016

EVOSCIENCES

Wednesday November 23rd, 2016|

VitaDX and EVOSCIENCES enter into a partnership to facilitate access to the equipment required for the implementation of the VisioCyt® solution.

Monday November 21st, 2016

Second fundraising announcement

Monday November 21st, 2016|

The startup is officially starting its second round of fundraising of 1.5 M€ due in the first quarter of 2017 to support the development of its non-invasive medical device.

Friday April 1st, 2016

Monday February 1st, 2016

Labiotech

Monday February 1st, 2016|

Making Bladder Cancer Cells Glow earns French Biotech €1.5M

Friday January 15th, 2016

Friday January 1st, 2016

Thursday October 1st, 2015

Rennes Atalante

Thursday October 1st, 2015|

The former President of Vitalitec becomes Chairman of the Board of VitaDX

Tuesday September 1st, 2015